We hosted local and international media who visited the Programme to cover the programme’s response to the COVID-19 pandemic and the beginning of the ChAdOx1 nCoV -19 vaccine trial.

Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating a leading COVID-19 vaccine candidate ChAdOx1 nCoV-19.